Combined Postoperative Radiotherapy With Kidney Sparing Surgery for Locally Advanced High-risk Ureteral Cancer

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure, Radiation
Study Type: Observational
SUMMARY

In this study, we propose to conduct an ambispective study to analyze the safety of preserved renal unit surgery combined with postoperative adjuvant radiotherapy in patients with limited stage ureteral cancer with high risk factors, and the efficacy analysis compared with traditional radical surgery. It is hoped that a treatment method that preserves patients' renal function to improve the tolerance of subsequent drug therapy without decreasing the effect of tumor treatment can be achieved in patients with high-risk factors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \- 1) Ureteral cancer patients with high-risk factors (high-risk factors define multifocal; G3; T2-4); surgery may be performed with patients undergoing partial terminal ureteral resection or radical nephroureterectomy 2)Age ≥18 years; 3)Completion of abdominopelvic CT 4 weeks before enrollment to exclude distant metastasis and regional lymph node metastasis.

• 4\) Patients did not have other malignant neoplastic diseases in the last 5 years except for non-melanoma of the skin and ductal carcinoma in situ of the breast; Willing to participate in perfecting the necessary examinations and follow-up for the sake of the study, and willing to provide written informed consent.

Locations
Other Locations
China
Departmeng of Urology, Peking University First Hospital
RECRUITING
Beijing
Department of Radiotherapy Oncology, Peking University First Hospital
RECRUITING
Beijing
Time Frame
Start Date: 2023-11-10
Estimated Completion Date: 2028-11-09
Participants
Target number of participants: 90
Treatments
Kidney sparing surgery+Postoperative radiotheray cohort
Kidney sparing surgery+Postoperative radiotheray cohort
Radical surgery cohort
Preoperative CT/MRI, chest CT and other examinations are performed to determine the stage of the patient's disease. The surgical plan is the same as the current conventional treatment. After surgery, there is no restriction on the use of postoperative adjuvant chemotherapy or postoperative adjuvant radiotherapy according to the patient's pathological stage and the patient's wish.
Related Therapeutic Areas
Sponsors
Leads: Xuesong Li

This content was sourced from clinicaltrials.gov